396 related articles for article (PubMed ID: 3141002)
1. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
Zhang WQ; Tilson HA; Nanry KP; Hudson PM; Hong JS; Stachowiak MK
Brain Res; 1988 Oct; 461(2):335-42. PubMed ID: 3141002
[TBL] [Abstract][Full Text] [Related]
2. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.
Robinson TE; Whishaw IQ
Brain Res; 1988 May; 450(1-2):209-24. PubMed ID: 3135914
[TBL] [Abstract][Full Text] [Related]
3. Preservation of dopamine release in the denervated striatum.
Altar CA; Marien MR
Neurosci Lett; 1989 Jan; 96(3):329-34. PubMed ID: 2497410
[TBL] [Abstract][Full Text] [Related]
4. Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions.
Brannan T; Bhardwaj A; Martinez-Tica J; Weinberger J; Yahr M
J Neural Transm Park Dis Dement Sect; 1990; 2(1):15-22. PubMed ID: 2113388
[TBL] [Abstract][Full Text] [Related]
5. Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.
Javoy F; Sotelo C; Herbet A; Agid Y
Brain Res; 1976 Feb; 102(2):201-15. PubMed ID: 1247882
[TBL] [Abstract][Full Text] [Related]
6. Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs.
Hefti F; Enz A; Melamed E
Neuropharmacology; 1985 Jan; 24(1):19-23. PubMed ID: 2858830
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.
Abarca J; Bustos G
Neurochem Int; 1999 Jul; 35(1):19-33. PubMed ID: 10403427
[TBL] [Abstract][Full Text] [Related]
8. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
Konieczny J; Lenda T; Czarnecka A
Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686
[TBL] [Abstract][Full Text] [Related]
9. Activation of striatal neurons by dexamphetamine is antagonized by degeneration of striatal dopaminergic terminals.
Warenycia MW; McKenzie GM
J Neural Transm; 1987; 70(3-4):217-32. PubMed ID: 3119772
[TBL] [Abstract][Full Text] [Related]
10. Nigrostriatal dopamine mediates the stimulatory effects of corticotropin releasing factor on methionine-enkephalin and dynorphin release from the rat neostriatum.
Sirinathsinghji DJ; Nikolarakis KE; Reimer S; Herz A
Brain Res; 1990 Aug; 526(1):173-6. PubMed ID: 1981853
[TBL] [Abstract][Full Text] [Related]
11. Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage.
Stachowiak MK; Keller RW; Stricker EM; Zigmond MJ
J Neurosci; 1987 Jun; 7(6):1648-54. PubMed ID: 3110381
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
[TBL] [Abstract][Full Text] [Related]
13. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
14. Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson's disease.
Lin L; Meng T; Liu T; Zheng Z
Life Sci; 2013 Mar; 92(4-5):311-6. PubMed ID: 23333823
[TBL] [Abstract][Full Text] [Related]
15. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
Costall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
[TBL] [Abstract][Full Text] [Related]
16. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
Snyder GL; Keller RW; Zigmond MJ
J Pharmacol Exp Ther; 1990 May; 253(2):867-76. PubMed ID: 2110978
[TBL] [Abstract][Full Text] [Related]
17. Striatal trophic activity is reduced in the aged rat brain.
Ling ZD; Collier TJ; Sortwell CE; Lipton JW; Vu TQ; Robie HC; Carvey PM
Brain Res; 2000 Feb; 856(1-2):301-9. PubMed ID: 10677639
[TBL] [Abstract][Full Text] [Related]
18. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system.
Robinson TE; Mocsary Z; Camp DM; Whishaw IQ
J Neurosci; 1994 May; 14(5 Pt 1):2687-96. PubMed ID: 7514209
[TBL] [Abstract][Full Text] [Related]
19. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats.
Robertson GS; Damsma G; Fibiger HC
J Neurosci; 1991 Jul; 11(7):2209-16. PubMed ID: 1712381
[TBL] [Abstract][Full Text] [Related]
20. Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum.
Li SJ; Jiang HK; Stachowiak MS; Hudson PM; Owyang V; Nanry K; Tilson HA; Hong JS
Brain Res Mol Brain Res; 1990 Aug; 8(3):219-25. PubMed ID: 1977070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
